Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
GBP 525M -
Notice Type:
Contract Notice
Published Date:
25 October 2018
Closing Date:
26 November 2018
Location(s):
UKC NORTH EAST (ENGLAND) (UK UNITED KINGDOM)
UKD NORTH WEST (ENGLAND) (UK UNITED KINGDOM)
UKE YORKSHIRE AND THE HUMBER (UK UNITED KINGDOM)
Description:

NHS Framework Agreement for Branded Medicines — North of England — Tranche A

Offer reference number: CM/PHR/16/5526

Period of Framework Agreement:

CM/PHR/16/5526/01 — 1.3.2019 – 28.2.2021 (with an option to extend at the authority’s discretion by up to 24 months)

CM/PHR/16/5526/02 — 1.3.2019 — 29.2.2020 (with an option to extend at the authority’s discretion by up to 12 months)

The framework is intended for use by the Department of Health and Social Care, Public Health England and the NHS in England.

The framework may also be used by private sector contractors and agents working on behalf of the above.



Products associated with the lots are listed on Document No. 05 of the Invitation to Offer. Each individual National Product Code (NPC) pack description in each of the regions (North of England) is deemed to be a separate product for the application of the award criteria. There is no restriction on the number of products that bidders can offer for, or be awarded. The Framework Agreement is intended for use by the Department of Health, Public Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above

Download full details as .pdf
The Buyer:
NHS Commissioning Board (operating under the name of NHS England)
CPV Code(s):
33600000 - Pharmaceutical products